Brief: Virpax Announces Positive Results For The Swine Model Dose Range Finding Study For Probudur™
Nov 22 (Reuters) - Range Resources Corp RRC.N :
* VIRPAX ANNOUNCES POSITIVE RESULTS FOR THE SWINE MODEL DOSE
RANGE
FINDING STUDY FOR PROBUDUR™
* VIRPAX PHARMACEUTICALS INC - MINIPIGS SHOW POSITIVE
TOLERANCE TO
PROBUDUR WITH NO ADVERSE EFFECTS
Source text: ID:nBwm5NRVa
Further company coverage: RRC.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Virpax Pharmaceuticals
See all newsVirpax Pharma plunges as Nasdaq delisting looms
Brief: Virpax Pharmaceuticals Files For Offering On Best Efforts Basis Up To 2.4 Million Shares Of Common Stock
Brief: Virpax receives positive Probudur™ results for dose range study
Brief: Virpax Looking To Use Met To Develop Intranasal Covid Vaccine
Brief: Virpax Confirms Positive Results With Us Army With Probudur™ For Combat Care Study